Literature DB >> 23562430

Neuropsychiatric symptoms in Alzheimer's disease: past progress and anticipation of the future.

Yonas E Geda1, Lon S Schneider, Laura N Gitlin, David S Miller, Gwenn S Smith, Joanne Bell, Jovier Evans, Michael Lee, Anton Porsteinsson, Krista L Lanctôt, Paul B Rosenberg, David L Sultzer, Paul T Francis, Henry Brodaty, Prasad P Padala, Chiadikaobi U Onyike, Luis Agüera Ortiz, Sonia Ancoli-Israel, Donald L Bliwise, Jennifer L Martin, Michael V Vitiello, Kristine Yaffe, Phyllis C Zee, Nathan Herrmann, Robert A Sweet, Clive Ballard, Ni A Khin, Cara Alfaro, Patrick S Murray, Susan Schultz, Constantine G Lyketsos.   

Abstract

Neuropsychiatric symptoms (NPS) in Alzheimer's disease (AD) are widespread and disabling. This has been known since Dr. Alois Alzheimer's first case, Frau Auguste D., presented with emotional distress and delusions of infidelity/excessive jealousy, followed by cognitive symptoms. Being cognizant of this, in 2010 the Alzheimer's Association convened a research roundtable on the topic of NPS in AD. A major outcome of the roundtable was the founding of a Professional Interest Area (PIA) within the International Society to Advance Alzheimer's Research and Treatment (ISTAART). The NPS-PIA has prepared a series of documents that are intended to summarize the literature and provide more detailed specific recommendations for NPS research. This overview paper is the first of these living documents that will be updated periodically as the science advances. The overview is followed by syndrome-specific synthetic reviews and recommendations prepared by NPS-PIA workgroups on depression, apathy, sleep, agitation, and psychosis.
Copyright © 2013 The Alzheimer's Association. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Agitation/aggression; Alzheimer's disease; Apathy; Behavioral and psychological symptoms of dementia; Delusions; Dementia; Depression; Hallucinations; Mild behavioral impairment; Mild cognitive impairment; Neuropsychiatric symptoms; Psychosis; Sleep disorders

Mesh:

Year:  2013        PMID: 23562430      PMCID: PMC3766403          DOI: 10.1016/j.jalz.2012.12.001

Source DB:  PubMed          Journal:  Alzheimers Dement        ISSN: 1552-5260            Impact factor:   21.566


  61 in total

Review 1.  Translational research in late-life mood disorders: implications for future intervention and prevention research.

Authors:  Gwenn S Smith; Faith M Gunning-Dixon; Francis E Lotrich; Warren D Taylor; Jovier D Evans
Journal:  Neuropsychopharmacology       Date:  2007-02-28       Impact factor: 7.853

2.  Scales as outcome measures for Alzheimer's disease.

Authors:  Ronald Black; Barry Greenberg; J Michael Ryan; Holly Posner; Jeffrey Seeburger; Joan Amatniek; Malca Resnick; Richard Mohs; David S Miller; Daniel Saumier; Maria C Carrillo; Yaakov Stern
Journal:  Alzheimers Dement       Date:  2009-07       Impact factor: 21.566

3.  The Neuropsychiatric Inventory-Clinician rating scale (NPI-C): reliability and validity of a revised assessment of neuropsychiatric symptoms in dementia.

Authors:  Kate de Medeiros; P Robert; S Gauthier; F Stella; A Politis; J Leoutsakos; F Taragano; J Kremer; A Brugnolo; A P Porsteinsson; Y E Geda; H Brodaty; G Gazdag; J Cummings; C Lyketsos
Journal:  Int Psychogeriatr       Date:  2010-07-01       Impact factor: 3.878

Review 4.  Genetics of psychosis in Alzheimer's disease: a review.

Authors:  Mary Ann DeMichele-Sweet; Robert A Sweet
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

5.  Neuropsychiatric predictors of progression from amnestic-mild cognitive impairment to Alzheimer's disease: the role of depression and apathy.

Authors:  Katie Palmer; Fulvia Di Iulio; Ambra Erika Varsi; Walter Gianni; Giuseppe Sancesario; Carlo Caltagirone; Gianfranco Spalletta
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

6.  Quetiapine treatment for behavioural and psychological symptoms of dementia in Alzheimer's disease patients: a 6-week, double-blind, placebo-controlled study.

Authors:  D Paleacu; Y Barak; I Mirecky; D Mazeh
Journal:  Int J Geriatr Psychiatry       Date:  2008-04       Impact factor: 3.485

7.  Imaging Alzheimer pathology in late-life depression with PET and Pittsburgh Compound-B.

Authors:  Meryl A Butters; William E Klunk; Chester A Mathis; Julie C Price; Scott K Ziolko; Jessica A Hoge; Nicholas D Tsopelas; Brian J Lopresti; Charles F Reynolds; Steven T DeKosky; Carolyn C Meltzer
Journal:  Alzheimer Dis Assoc Disord       Date:  2008 Jul-Sep       Impact factor: 2.703

8.  Increased striatal dopamine (D2/D3) receptor availability and delusions in Alzheimer disease.

Authors:  Suzanne Reeves; Richard Brown; Robert Howard; Paul Grasby
Journal:  Neurology       Date:  2009-02-10       Impact factor: 9.910

9.  Prevalence of neuropsychiatric symptoms in mild cognitive impairment and normal cognitive aging: population-based study.

Authors:  Yonas E Geda; Rosebud O Roberts; David S Knopman; Ronald C Petersen; Teresa J H Christianson; Vernon S Pankratz; Glenn E Smith; Bradley F Boeve; Robert J Ivnik; Eric G Tangalos; Walter A Rocca
Journal:  Arch Gen Psychiatry       Date:  2008-10

10.  Cholinergic modulation of the cerebral metabolic response to citalopram in Alzheimer's disease.

Authors:  Gwenn S Smith; Elisse Kramer; Yilong Ma; Carol R Hermann; Vijay Dhawan; Thomas Chaly; David Eidelberg
Journal:  Brain       Date:  2009-01-19       Impact factor: 13.501

View more
  110 in total

Review 1.  Non-pharmacological Management of Behavioral Symptoms in Frontotemporal and Other Dementias.

Authors:  Cynthia Barton; Robin Ketelle; Jennifer Merrilees; Bruce Miller
Journal:  Curr Neurol Neurosci Rep       Date:  2016-02       Impact factor: 5.081

2.  Incident Psychosis in Subjects With Mild Cognitive Impairment or Alzheimer's Disease.

Authors:  Elise A Weamer; Mary Ann A DeMichele-Sweet; Yona K Cloonan; Oscar L Lopez; Robert A Sweet
Journal:  J Clin Psychiatry       Date:  2016-12       Impact factor: 4.384

Review 3.  Neuropsychiatric symptoms in Alzheimer's disease: What might be associated brain circuits?

Authors:  Paul B Rosenberg; Milap A Nowrangi; Constantine G Lyketsos
Journal:  Mol Aspects Med       Date:  2015-06-03

4.  Delusions in Alzheimer Disease: What Researchers Should Not Forget.

Authors:  Konasale M Prasad
Journal:  Am J Geriatr Psychiatry       Date:  2019-01-09       Impact factor: 4.105

Review 5.  Cannabinoids for Agitation in Alzheimer's Disease.

Authors:  John D Outen; M Haroon Burhanullah; Ryan Vandrey; Halima Amjad; David G Harper; Regan E Patrick; Rose L May; Marc E Agronin; Brent P Forester; Paul B Rosenberg
Journal:  Am J Geriatr Psychiatry       Date:  2021-01-27       Impact factor: 4.105

Review 6.  Comorbidities in Neurology: Is adenosine the common link?

Authors:  Detlev Boison; Eleonora Aronica
Journal:  Neuropharmacology       Date:  2015-05-13       Impact factor: 5.250

7.  Self-reported personality traits are prospectively associated with proxy-reported behavioral and psychological symptoms of dementia at the end of life.

Authors:  Angelina R Sutin; Yannick Stephan; Martina Luchetti; Antonio Terracciano
Journal:  Int J Geriatr Psychiatry       Date:  2017-09-04       Impact factor: 3.485

Review 8.  Contributions of adult neurogenesis to dentate gyrus network activity and computations.

Authors:  Sebnem Nur Tuncdemir; Clay Orion Lacefield; Rene Hen
Journal:  Behav Brain Res       Date:  2019-08-01       Impact factor: 3.332

9.  Alzheimer's disease first symptoms are age dependent: Evidence from the NACC dataset.

Authors:  Josephine Barnes; Bradford C Dickerson; Chris Frost; Lize C Jiskoot; David Wolk; Wiesje M van der Flier
Journal:  Alzheimers Dement       Date:  2015-04-24       Impact factor: 21.566

Review 10.  Late-onset Alzheimer Disease.

Authors:  Gil D Rabinovici
Journal:  Continuum (Minneap Minn)       Date:  2019-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.